16 January 2023
Antibodies | Issue Cover Papers in 2021–2022
You are accessing a machine-readable page. In order to be human-readable, please install an RSS reader.
All articles published by MDPI are made immediately available worldwide under an open access license. No special permission is required to reuse all or part of the article published by MDPI, including figures and tables. For articles published under an open access Creative Common CC BY license, any part of the article may be reused without permission provided that the original article is clearly cited. For more information, please refer to https://www.mdpi.com/openaccess.
Feature papers represent the most advanced research with significant potential for high impact in the field. A Feature Paper should be a substantial original Article that involves several techniques or approaches, provides an outlook for future research directions and describes possible research applications.
Feature papers are submitted upon individual invitation or recommendation by the scientific editors and must receive positive feedback from the reviewers.
Editor’s Choice articles are based on recommendations by the scientific editors of MDPI journals from around the world. Editors select a small number of articles recently published in the journal that they believe will be particularly interesting to readers, or important in the respective research area. The aim is to provide a snapshot of some of the most exciting work published in the various research areas of the journal.
Original Submission Date Received: .
1. "Viroinformatics-Based Analysis of SARS-CoV-2 Core Proteins for Potential Therapeutic Targets"
by Lokesh Agrawal, Thanasis Poullikkas, Scott Eisenhower, Carlo Monsanto, Ranjith Kumar Bakku, Min-Hua Chen and Rajkumar Singh Kalra
Antibodies 2021, 10(1), 3; https://doi.org/10.3390/antib10010003
Available online: https://www.mdpi.com/2073-4468/10/1/3
2. "Recombinant Antibody Production Using a Dual-Promoter Single Plasmid System"
by Stefania C. Carrara, David Fiebig, Jan P. Bogen, Julius Grzeschik, Björn Hock and Harald Kolmar
Antibodies 2021, 10(2), 18; https://doi.org/10.3390/antib10020018
Available online: https://www.mdpi.com/2073-4468/10/2/18
3. "Beyond the Lactate Paradox: How Lactate and Acidity Impact T Cell Therapies against Cancer"
by Violet Y. Tu, Asma Ayari and Roddy S. O’Connor
Antibodies 2021, 10(3), 25; https://doi.org/10.3390/antib10030025
Available online: https://www.mdpi.com/2073-4468/10/3/25
4. "Engineered mRNA and the Rise of Next-Generation Antibodies"
by Laura Sanz and Luis Álvarez-Vallina
Antibodies 2021, 10(4), 37; https://doi.org/10.3390/antib10040037
Available online: https://www.mdpi.com/2073-4468/10/4/37
5. "Applications of Antibody-Based Antigen Delivery Targeted to Dendritic Cells In Vivo"
by Jessica Bourque and Daniel Hawiger
Antibodies 2022, 11(1), 8; https://doi.org/10.3390/antib11010008
Available online: https://www.mdpi.com/2073-4468/11/1/8
6. "Strategies to Screen Anti-AQP4 Antibodies from Yeast Surface Display Libraries"
by Aric Huang, Wei Jin, Ahmed S. Fahad, Brooklyn K. Mussman, Grazia Paola Nicchia, Bharat Madan, Matheus Oliveira de Souza, J. Daniel Griffin, Jeffrey L. Bennett, Antonio Frigeri et al.
Antibodies 2022, 11(2), 39; https://doi.org/10.3390/antib11020039
Available online: https://www.mdpi.com/2073-4468/11/2/39
7. "Mitochondrial Autoantibodies and the Role of Apoptosis in Pemphigus Vulgaris"
by Dana M. Hutchison, Anna-Marie Hosking, Ellen M. Hong, and Sergei A. Grando
Antibodies 2022, 11(3), 55; https://doi.org/10.3390/antib11030055
Available online: https://www.mdpi.com/2073-4468/11/3/55
8. "Structural Investigation of Therapeutic Antibodies Using Hydroxyl Radical Protein Footprinting Methods"
by Corie Y. Ralston and Joshua S. Sharp
Antibodies 2022, 11(4), 71; https://doi.org/10.3390/antib11040071
Available online: https://www.mdpi.com/2073-4468/11/4/71